Reduced plasma orexin-A levels in patients with bipolar disorder

Shoko Tsuchimine,1 Kotaro Hattori,1 Miho Ota,1 Shinsuke Hidese,1 Toshiya Teraishi,1 Daimei Sasayama,1 Hiroaki Hori,1 Takamasa Noda,2 Sumiko Yoshida,2 Fuyuko Yoshida,1 Hiroshi Kunugi11Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Orexin-A Plasma Schizophrenia Major depressive disorder Bipolar disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6823340e0a4342fb8ccdaf4e55c9efe0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6823340e0a4342fb8ccdaf4e55c9efe0
record_format	dspace
spelling	oai:doaj.org-article:6823340e0a4342fb8ccdaf4e55c9efe02021-12-02T09:30:15ZReduced plasma orexin-A levels in patients with bipolar disorder1178-2021https://doaj.org/article/6823340e0a4342fb8ccdaf4e55c9efe02019-08-01T00:00:00Zhttps://www.dovepress.com/reduced-plasma-orexin-a-levels-in-patients-with-bipolar-disorder-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Shoko Tsuchimine,1 Kotaro Hattori,1 Miho Ota,1 Shinsuke Hidese,1 Toshiya Teraishi,1 Daimei Sasayama,1 Hiroaki Hori,1 Takamasa Noda,2 Sumiko Yoshida,2 Fuyuko Yoshida,1 Hiroshi Kunugi11Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; 2Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo 187-8551, JapanPurpose: Orexins are hypothalamic neuropeptides involved in the regulation of sleep, appetite and arousal. An altered orexin system has been implicated in the pathophysiology of psychiatric disorders. This study aimed to examine whether plasma orexin-A levels differ in patients with schizophrenia, major depressive disorder (MDD), or bipolar disorder (BD) compared to in healthy controls. We also examined the possible correlations between plasma orexin-A levels and clinical variables.Patients and methods: All participants were Japanese. The sample consisted of 80 patients with schizophrenia (42 women, 52.5%; mean age 36.8 years), 80 patients with MDD (43 women, 53.8%; 43.7 years), and 40 patients with BD (24 women, 60%; 41.1 years), as well as 80 healthy controls (48 women, 60%; 47.0 years). Plasma orexin-A levels were quantified by an enzyme-linked immunosorbent assay.Results: Mean orexin-A levels were significantly different across the four diagnostic groups (F=4.09; df=3; p=0.007, η2=0.06). In particular, the patients with BD showed significantly lower orexin-A levels than did the controls. When the median value of the control group (109.8 pg/ml) was set as a cut-off value, subjects whose orexin-A levels were below the cut-off were more common in all psychiatric groups (schizophrenia: 73.8%, x2=9.56, df=1, p=0.003, OR=2.81, 95% CI: 1.45 to 5.45, d=0.57; MDD: 78.5%, x2=14.02, df=1, p<0.001, OR=3.65, 95% CI: 1.82 to 7.29, d=0.72; BD: 87.5%, x2=16.0, df=1, p<0.001, OR=7.00, 95% CI: 2.49 to 19.70, d=1.07). We found no association between plasma orexin-A levels and any clinical symptoms, depression severity, or medication doses.Conclusion: Our results suggest that plasma orexin-A levels are reduced in patients with BD.Keywords: orexin-A, plasma, schizophrenia, major depressive disorder, bipolar disorder  Tsuchimine SHattori KOta MHidese STeraishi TSasayama DHori HNoda TYoshida SYoshida FKunugi HDove Medical PressarticleOrexin-APlasmaSchizophreniaMajor depressive disorderBipolar disorderNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 2221-2230 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Orexin-A Plasma Schizophrenia Major depressive disorder Bipolar disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Orexin-A Plasma Schizophrenia Major depressive disorder Bipolar disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Tsuchimine S Hattori K Ota M Hidese S Teraishi T Sasayama D Hori H Noda T Yoshida S Yoshida F Kunugi H Reduced plasma orexin-A levels in patients with bipolar disorder
description	Shoko Tsuchimine,1 Kotaro Hattori,1 Miho Ota,1 Shinsuke Hidese,1 Toshiya Teraishi,1 Daimei Sasayama,1 Hiroaki Hori,1 Takamasa Noda,2 Sumiko Yoshida,2 Fuyuko Yoshida,1 Hiroshi Kunugi11Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; 2Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo 187-8551, JapanPurpose: Orexins are hypothalamic neuropeptides involved in the regulation of sleep, appetite and arousal. An altered orexin system has been implicated in the pathophysiology of psychiatric disorders. This study aimed to examine whether plasma orexin-A levels differ in patients with schizophrenia, major depressive disorder (MDD), or bipolar disorder (BD) compared to in healthy controls. We also examined the possible correlations between plasma orexin-A levels and clinical variables.Patients and methods: All participants were Japanese. The sample consisted of 80 patients with schizophrenia (42 women, 52.5%; mean age 36.8 years), 80 patients with MDD (43 women, 53.8%; 43.7 years), and 40 patients with BD (24 women, 60%; 41.1 years), as well as 80 healthy controls (48 women, 60%; 47.0 years). Plasma orexin-A levels were quantified by an enzyme-linked immunosorbent assay.Results: Mean orexin-A levels were significantly different across the four diagnostic groups (F=4.09; df=3; p=0.007, η2=0.06). In particular, the patients with BD showed significantly lower orexin-A levels than did the controls. When the median value of the control group (109.8 pg/ml) was set as a cut-off value, subjects whose orexin-A levels were below the cut-off were more common in all psychiatric groups (schizophrenia: 73.8%, x2=9.56, df=1, p=0.003, OR=2.81, 95% CI: 1.45 to 5.45, d=0.57; MDD: 78.5%, x2=14.02, df=1, p<0.001, OR=3.65, 95% CI: 1.82 to 7.29, d=0.72; BD: 87.5%, x2=16.0, df=1, p<0.001, OR=7.00, 95% CI: 2.49 to 19.70, d=1.07). We found no association between plasma orexin-A levels and any clinical symptoms, depression severity, or medication doses.Conclusion: Our results suggest that plasma orexin-A levels are reduced in patients with BD.Keywords: orexin-A, plasma, schizophrenia, major depressive disorder, bipolar disorder
format	article
author	Tsuchimine S Hattori K Ota M Hidese S Teraishi T Sasayama D Hori H Noda T Yoshida S Yoshida F Kunugi H
author_facet	Tsuchimine S Hattori K Ota M Hidese S Teraishi T Sasayama D Hori H Noda T Yoshida S Yoshida F Kunugi H
author_sort	Tsuchimine S
title	Reduced plasma orexin-A levels in patients with bipolar disorder
title_short	Reduced plasma orexin-A levels in patients with bipolar disorder
title_full	Reduced plasma orexin-A levels in patients with bipolar disorder
title_fullStr	Reduced plasma orexin-A levels in patients with bipolar disorder
title_full_unstemmed	Reduced plasma orexin-A levels in patients with bipolar disorder
title_sort	reduced plasma orexin-a levels in patients with bipolar disorder
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/6823340e0a4342fb8ccdaf4e55c9efe0
work_keys_str_mv	AT tsuchimines reducedplasmaorexinalevelsinpatientswithbipolardisorder AT hattorik reducedplasmaorexinalevelsinpatientswithbipolardisorder AT otam reducedplasmaorexinalevelsinpatientswithbipolardisorder AT hideses reducedplasmaorexinalevelsinpatientswithbipolardisorder AT teraishit reducedplasmaorexinalevelsinpatientswithbipolardisorder AT sasayamad reducedplasmaorexinalevelsinpatientswithbipolardisorder AT horih reducedplasmaorexinalevelsinpatientswithbipolardisorder AT nodat reducedplasmaorexinalevelsinpatientswithbipolardisorder AT yoshidas reducedplasmaorexinalevelsinpatientswithbipolardisorder AT yoshidaf reducedplasmaorexinalevelsinpatientswithbipolardisorder AT kunugih reducedplasmaorexinalevelsinpatientswithbipolardisorder
_version_	1718398070512680960

Reduced plasma orexin-A levels in patients with bipolar disorder

Ejemplares similares